Live Breaking News & Updates on Teine Keijinkai Hospital

Stay updated with breaking news from Teine keijinkai hospital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CMV: Fetal and neonatal therapies improve prognosis of congenital infection


A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.
It is hoped that the number of children suffering severe aftereffects resulting from congenital CMV infection will decrease in the future.
The research group included the following members:
Doctor YAMADA Hideto (Director of the Center for Recurrent Pregnancy Loss and Genome Medical Center, Teine Keijinkai Hospital, visiting professor at Osaka University and former professor of the Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine) ....

Department Of Obstetrics , Ichiro Department Of Pediatrics , Kobe University Hospital , Kenji Department Of Obstetrics , Research Findings , Osaka University , Kazumichi Department Of Pediatrics , Kobe University Graduate School Of Medicine , Research Background , Nihon University School Of Medicine , Department Of Pediatrics At Kobe University , Child Health , Genome Medical Center , Recurrent Pregnancy Loss , Teine Keijinkai Hospital , Kobe University Graduate School , Nihon University School , Reproductive Immunologyon December , Doctor Yamada , Kobe University , Auditory Brainstem Response , Developmental Quotient , துறை ஆஃப் மகப்பேறியல் , கோபி பல்கலைக்கழகம் மருத்துவமனை , கெஞ்சி துறை ஆஃப் மகப்பேறியல் , ஆராய்ச்சி கண்டுபிடிப்புகள் ,

Fetal and neonatal therapies improve prognosis of congenital cytomegalovirus infection


( 4), pleural effusion and peritoneal effusion
( 5) are among the characteristic symptoms of congenital CMV infection. Approximately 90% of infants who experience these clinical manifestations are left with the aforementioned severe aftereffects.
In recent years, it has been discovered that treating newborns with these clinical manifestations of congenital CMV infection with the antiviral drug, Valganciclovir, can improve not only hearing issues but also reduce delays in mental and physical development. In Japan, a clinical trial is ongoing to approve the neonatal therapies as treatments covered by public health insurance.
On the other hand, there are some cases where clear clinical manifestations of CMV infection can be diagnosed in fetuses via ultrasound while they are still in the uterus. It is supposed that infants who exhibit these symptoms in the uterus are more likely to experience more severe aftereffects than infants who are diagnosed with congenital CMV infe ....

Mizuki Uenaka , Kazumichi Fujioka , Toshihiko Ikuta , Toshio Minematsu , Hideto Yamada , Yutoku Shi , Ichiro Morioka , Masashi Deguchi , Kenji Tanimura , Hitomi Imafuku , Akiko Uchida , Department Of Obstetrics , Ichiro Department Of Pediatrics , Kobe University Hospital , Kenji Department Of Obstetrics , Research Findings , Kyoto Scale Of Psychological Development , Osaka University , Kazumichi Department Of Pediatrics , Kobe University Graduate School Of Medicine , Research Background , Nihon University School Of Medicine , Department Of Pediatrics At Kobe University , Child Health , Genome Medical Center , Recurrent Pregnancy Loss ,